Published in Arch Pathol Lab Med on January 01, 2007
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61
An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn (2010) 2.48
Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol (2014) 1.13
The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma. PLoS Curr (2013) 1.13
Molecular prognostic testing and individualized patient care in uveal melanoma. Am J Ophthalmol (2009) 1.07
A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile. Methods Mol Biol (2014) 1.00
Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma. Mod Pathol (2011) 1.00
Molecular pathology of uveal melanoma. Eye (Lond) (2012) 0.94
Prognostic parameters in uveal melanoma and their association with BAP1 expression. Br J Ophthalmol (2014) 0.93
Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration. Invest Ophthalmol Vis Sci (2010) 0.91
A molecular revolution in uveal melanoma: implications for patient care and targeted therapy. Ophthalmology (2014) 0.91
FISH analysis of chromosomes 3 and 6 on fine needle aspiration biopsy samples identifies distinct subgroups of uveal melanomas. J Cancer Res Clin Oncol (2008) 0.86
Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses. Clin Ophthalmol (2014) 0.84
In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up. Graefes Arch Clin Exp Ophthalmol (2007) 0.82
Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation. PLoS One (2014) 0.81
Heterogeneity of monosomy 3 in fine needle aspiration biopsy of choroidal melanoma. Mol Vis (2013) 0.78
iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors. PLoS One (2015) 0.78
Frequency and implications of discordant gene expression profile class in posterior uveal melanomas sampled by fine needle aspiration biopsy. Am J Ophthalmol (2014) 0.78
Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens. Exp Eye Res (2011) 0.75
The molecular classification of uveal melanocytic lesions: an important discovery in context. J Mol Diagn (2010) 0.75
Clinical and cytogenetic characteristics of choroidal melanoma in Vietnamese Asians. Mol Vis (2011) 0.75
Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2016) 0.75
FNA diagnosis of malignant melanoma-recurrent and metastatic disease. BMJ Case Rep (2012) 0.75
Case report: an atypical peripapillary uveal melanoma. BMC Ophthalmol (2014) 0.75
Intratumor and Intertumor Heterogeneity in Melanoma. Transl Oncol (2017) 0.75
Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma. Clin Cancer Res (2009) 2.04
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res (2007) 1.96
Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol (2011) 1.78
A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. Cancer Genet Cytogenet (2004) 1.77
HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion. Blood (2013) 1.65
Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm. Cancer Res (2010) 1.59
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother (2007) 1.47
Myiasis of the upper eyelid. J AAPOS (2008) 1.41
Detection of M2-macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci (2011) 1.37
Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol (2006) 1.33
Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci (2002) 1.33
Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene (2004) 1.32
Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab. Clin Cancer Res (2011) 1.24
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer. BMC Genomics (2007) 1.24
Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations. Cancer Res (2008) 1.23
Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma. Invest Ophthalmol Vis Sci (2008) 1.18
Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. Invest Ophthalmol Vis Sci (2010) 1.18
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes. Proc Natl Acad Sci U S A (2011) 1.17
In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages. J Immunol (2010) 1.15
Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol (2005) 1.12
Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma. Genes Chromosomes Cancer (2009) 1.12
High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin Cancer Res (2007) 1.12
Genetic variation of antigen processing machinery components and association with cervical carcinoma. Genes Chromosomes Cancer (2007) 1.11
Screening for refractive errors in children: the plusoptiX S08 and the Retinomax K-plus2 performed by a lay screener compared to cycloplegic retinoscopy. J AAPOS (2010) 1.10
Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition. J Pathol (2009) 1.09
Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 1.08
Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors. Int J Cancer (2010) 1.06
Authenticating cell lines in ophthalmic research laboratories. Invest Ophthalmol Vis Sci (2008) 1.03
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One (2012) 1.01
A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma. J Immunol (2007) 1.01
High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues. J Pathol (2005) 1.00
Regulation of VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci (2009) 1.00
Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer (2003) 0.98
Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival. Mod Pathol (2008) 0.97
Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma. Melanoma Res (2007) 0.96
Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye. J Immunol (2003) 0.96
Epigenetic inactivation of RASSF1a in uveal melanoma. Invest Ophthalmol Vis Sci (2007) 0.95
Heat shock protein expression in the eye and in uveal melanoma. Invest Ophthalmol Vis Sci (2003) 0.95
Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Arch Pathol Lab Med (2011) 0.95
Macrophages are vital in spontaneous intraocular tumor eradication. Invest Ophthalmol Vis Sci (2006) 0.94
Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas. BMC Cancer (2009) 0.94
Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol (2004) 0.94
The incidence of visually impaired children with retinopathy of prematurity and their concomitant disabilities. J AAPOS (2003) 0.93
Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma. Clin Cancer Res (2006) 0.92
Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma. PLoS One (2012) 0.92
Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer. Mod Pathol (2010) 0.91
Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration. Invest Ophthalmol Vis Sci (2010) 0.91
Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer. Mod Pathol (2011) 0.91
Epigenetic silencing of MHC2TA transcription in cancer. Biochem Pharmacol (2006) 0.91
The value of combining anterior segment fluorescein angiography with indocyanine green angiography in scleral inflammation. Ophthalmology (2003) 0.91
Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Biol Blood Marrow Transplant (2004) 0.90
Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis. Invest Ophthalmol Vis Sci (2005) 0.89
Frequent HLA class I loss is an early event in cervical carcinogenesis. Hum Immunol (2006) 0.88
Modulation of the tumor cell phenotype by IFN-gamma results in resistance of uveal melanoma cells to granule-mediated lysis by cytotoxic lymphocytes. J Immunol (2008) 0.88
Uveal melanoma: the inflammatory microenvironment. J Innate Immun (2012) 0.87
Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.87
The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty. Br J Ophthalmol (2012) 0.86
Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases. Clin Cancer Res (2012) 0.86
Melanoma vaccines: The problems of local immunosuppression. Hum Immunol (2009) 0.86
Prognostic value of S-100-beta serum concentration in patients with uveal melanoma. Arch Ophthalmol (2003) 0.86
Effective cooperation of monoclonal antibody and peptide vaccine for the treatment of mouse melanoma. J Immunol (2012) 0.85
HLA-E expression in cervical adenocarcinomas: association with improved long-term survival. J Transl Med (2012) 0.85
Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression. Invest Ophthalmol Vis Sci (2006) 0.85
FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma. Cancer Immunol Immunother (2015) 0.85
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinoma. Cancer Immunol Immunother (2015) 0.85
A fish scale-derived collagen matrix as artificial cornea in rats: properties and potential. Invest Ophthalmol Vis Sci (2013) 0.84
Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma. Radiother Oncol (2010) 0.84
Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens. Invest Ophthalmol Vis Sci (2005) 0.84
Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reaction. J Immunol (2004) 0.84
Expression of CD133 and other putative stem cell markers in uveal melanoma. Melanoma Res (2011) 0.83
Expression and genetic analysis of transporter associated with antigen processing in cervical carcinoma. Gynecol Oncol (2007) 0.83
Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 0.83
Physical status of multiple human papillomavirus genotypes in flow-sorted cervical cancer cells. Cancer Genet Cytogenet (2007) 0.83
Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma. Melanoma Res (2007) 0.83
Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection. Int J Cancer (2011) 0.83
Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Invest Ophthalmol Vis Sci (2009) 0.82
Maintenance of immune tolerance depends on normal tissue homeostasis. J Immunol (2005) 0.82
Bevacizumab and intraocular tumors: an intriguing paradox. Mol Vis (2012) 0.82
Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.81
Anti-angiogenic therapy in uveal melanoma. Dev Ophthalmol (2011) 0.81
Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype. Invest Ophthalmol Vis Sci (2010) 0.81
Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells. Cancer Immunol Immunother (2006) 0.81
Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer (2005) 0.81
Expression of coinhibitory receptors on T cells in the microenvironment of usual vulvar intraepithelial neoplasia is related to proinflammatory effector T cells and an increased recurrence-free survival. Int J Cancer (2014) 0.81
Differences in genetic variation in antigen-processing machinery components and association with cervical carcinoma risk in two Indonesian populations. Immunogenetics (2015) 0.81
Presence and maturity of dendritic cells in melanoma lymph node metastases. J Pathol (2005) 0.81
High levels of Hdmx promote cell growth in a subset of uveal melanomas. Am J Cancer Res (2012) 0.80
ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion. Pigment Cell Melanoma Res (2014) 0.80
Genetics of primary intraocular tumors. Ocul Immunol Inflamm (2012) 0.80